Funding Sources

In addition to founder contributions, BrachyFoam has been fortunate to receive financial support in the form of grant funding from the National Cancer Institute and the Commonwealth Research Commercialization Fund:

  • National Cancer Institute (NCI) Small Business Technology Transfer (STTR) Award (1R41CA203171-01A1): Self-expanding hydrogel for pelvic brachytherapy: a novel method for vaginal packing and customized radiation therapy.
    • Awarded in 2017
  • Commonwealth Research Commercialization Fund STTR Matching Award (STTR18-002-LS): Development and validation of delivery system for commercialization of self-expanding hydrogel for pelvic brachytherapy.
    • Awarded in 2018
  • National Cancer Institute (NCI) Small Business Technology Transfer (STTR) Award (2R42CA203171-02A1): Clinical validation and commercialization of a novel hydrogel-based vaginal packing system for pelvic brachytherapy.
    • Awarded in 2019

BrachyFoam has a licensing agreement established with the University of Virginia Licensing & Ventures Group to develop a patented hydrogel technology developed by a collaborative team of researchers from UVA and Virginia Tech.